Action Observation Theraphy in Severe Acquired Brain Injury.
Evaluation of the Effectiveness of Action Observation Theraphy (AOT) in Patients with Severe Acquired Brain Injury (sABI).
1 other identifier
interventional
24
1 country
1
Brief Summary
Action Observation Therapy (AOT) is a rehabilitation technique, used for several years, aimed at the recovery of motor function in patients with neurological and orthopedic conditions. The essential element of this approach is the patient's observation and subsequent mime of a sequence of daily actions, aimed at achieving a goal. This task is proposed repeatedly during a single rehabilitation session and repeated for a set number of sessions. The recovery of the presented motor patterns has, as its ultimate goal, the improvement of autonomy in activities of daily living (ADLs). The neurophysiological mechanism underlying motor cortical recovery is related to the activation of mirror neuron circuits and includes mechanisms of neuronal plasticity. In fact, it is well known how motor brain areas injured by a pathological process are able to activate during tasks of imagining or observing movements, with a correspondence between the type of movement observed and the specific motor cortical region involved in the given action. Activation of the brain areas in charge of movement, in addition to keeping the uninjured networks functioning, stimulates the injured ones by promoting, by mechanisms of neuronal plasticity, a reorganization of the primary motor cortex. The physiological basis for motor learning would thus be established, the cortical reorganization being decisive for the formation of a motor memory of the observed gesture and allowing the reacquisition, even partial, of the function of the injured motor cortex. Finally, motor cortical stimulation has a function in preventing dysfunctional cortical reorganization that intervenes after inactivity or disuse. As revealed by systematic review studies on the subject, the protocols used are very heterogeneous in terms of the type of patients to whom they were offered, the type and number of actions shown during treatments, their duration, and the rating scales used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedFirst Submitted
Initial submission to the registry
February 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedMarch 20, 2025
December 1, 2024
9 months
February 17, 2023
March 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motricity Index Upper Limb (MI-UL)
MI-UL can be used to assess the motor impairment in a patient who has had a stroke. Test for each upper limb: 1. pincer grip 2. elbow flexion 3. shoulder abduction For the pincer grip: 0 points, no movement 19 points, grip possible but not against gravity 33 points, normal grip For all other items: 0 points, no movement 14 points, Visible movement but not for the entire joint range or against gravity 19 points, movement possible for the entire joint range against gravity but not against resistance 33 points movement performed with normal force Each segment has a total score obtained by adding the value "1" to the score of each individual item. The total score then ranges from 1 (no movement) to 100 (normal movement).
Change from baseline MI-UL at 3 weeks
Secondary Outcomes (8)
Motor Assessment Scale (MAS)
Change from baseline MAS at 3 weeks
Nine Hole Peg Test (9HPT)
Change from baseline 9HPT at 3 weeks
Coma Recovery Scale-revised (CRS-r)
Change from baseline CRS-r at 3 weeks
Level of Cognitive Functioning (LCF)
Change from baseline LCF at 3 weeks
Glasgow Outcome Scale-Extended (GOS-E)
Change from baseline GOS-E at 3 weeks
- +3 more secondary outcomes
Study Arms (2)
Group Action Observation Therapy (G-AOT)
EXPERIMENTALG-AOT patients will carry out AOT therapy in addition to conventional rehabilitation therapies. In case of bilateral clinical engagement, treatment with AOT will have been conducted on the limb that on motor outcome measures appears less involved. G-AOT patients will undergo rehabilitation treatment with AOT once a day, 5 days a week. 15 sessions will then be given, for a total duration of 3 weeks of experimental treatment with AOT.
Group Conventional (G-CONV)
ACTIVE COMPARATORG-CONV patients will only carry out rehabilitation treatments as per clinical practice.
Interventions
Using a 13-inch tablet, the patient will be shown, from a third-person lateral perspective framing the palmar side of the hand, a video that repeatedly plays a simple movement of daily life (grasping a glass on the table with the hand and bringing it closer to oneself) for 5 consecutive minutes. The video should be customized based on the side being treated (ex: right hemiparesis, video framing a right hand). After 1 minute of rest, the therapist will ask the patient to perform the newly observed movement for a minimum duration of 2 minutes and a maximum of 5 minutes. The cycle will be repeated a total of 3 times, for total treatment time between 25 and 35 minutes per session.
Conventional treatment will focus on joint mobilization, muscle stretching, and neuromuscular facilitation activities, using the main rehabilitation methods (e.g., neurocognitive theory, Bobath Concept, Progressive Neuromuscular Facilitation, etc.).
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years;
- Having presented with a documented coma state with Glasgow Coma Scale (GCS) values ≤ 8, for at least 24 consecutive hours;
- Minimal Consciousness State (MCS) or emergence from Minimal Consciousness State (eMCS)
- Presence of muscle activity in at least one upper limb,
- Traumatic, cerebrovascular, anoxic, infectious, metabolic etiology;
- Time since acute event: 1 - 4 months;
- Unilateral or bilateral clinical involvement;
You may not qualify if:
- Patients in a comatose or vegetative state (VS)
- premorbid history of psychiatric or neurological conditions;
- concomitant presence of sepsis, coma, or other medical conditions that severely alter the patient's health status;
- Changes in therapy, during the study period, that may affect vigilance status (antiepileptic drugs, antidepressants, etc.) or spasticity;
- Presence of upper limb fractures;
- Level of spasticity Ashworth modified≥ 3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM, 00168, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Padua, MD, phD
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 17, 2023
First Posted
February 28, 2023
Study Start
December 20, 2021
Primary Completion
September 30, 2022
Study Completion
April 30, 2024
Last Updated
March 20, 2025
Record last verified: 2024-12